Promising seizure drug for rare genetic disorder enters final testing phase
Disease control
Ongoing
This study tests a medicine called ZX008 (fenfluramine) to see if it can safely reduce seizures in children and adults with CDKL5 deficiency disorder, a rare genetic condition that causes severe epilepsy and developmental delays. About 87 participants aged 1 to 35 who have not ha…
Phase: PHASE3 • Sponsor: Zogenix, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC